INFLUENCE OF THE INTERVAL OF TIME BETWEEN ANTI-TNF AND VEDOLIZUMAB OR USTEKINUMAB IN THE RESPONSE TO TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Baston-Rey  1     Manuel Barreiro de Acosta  1     Marta Costa  1     Cristina Calviño Suarez  1     Violeta Mauriz-Barreiro  2     Daniel de la Iglesia-Garcia     Jaime González     Rocío Ferreiro-Iglesias     J. Enrique Dominguez-Munoz    
1 University Hospital of Santiago de Compostela,Santiago de Compostela,Spain
2 University Hospital of Santiago d

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing